Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$13,526.92
% of Total Estimate Gain
2.29%

PRENTISS SMITH & CO INC's Neurocrine Biosciences Inc Holding Summary

As of 2025-03-31, PRENTISS SMITH & CO INC held - shares of Neurocrine Biosciences Inc(NBIX), totaling N/A. This investment constitutes 0% of their stock portfolio, and PRENTISS SMITH & CO INC now holds 0% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.

The initial trade took place in 2024Q4. And since then PRENTISS SMITH & CO INC has made 1 purchases of NBIX, at an average price of $123.84, for a total of 4,763.00 shares. In addition, there have been 1 sales at an average price of $126.68 for 4,763.00 shares. Based on historical transaction data and NBIX's current price of $134.11, PRENTISS SMITH & CO INC's estimated gain on his NBIX holdings is $13,526.92, reflecting a 2.29% gain to date.

PRENTISS SMITH & CO INC NBIX ($134.11) Holding Chart

PRENTISS SMITH & CO INC NBIX ($134.11) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1